TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 139 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $596,000 | +3.1% | 147,819 | -2.0% | 0.00% | 0.0% |
| Q3 2016 | $578,000 | -11.1% | 150,906 | -0.1% | 0.00% | 0.0% |
| Q2 2016 | $650,000 | +13.8% | 151,120 | +22.5% | 0.00% | 0.0% |
| Q1 2016 | $571,000 | -52.9% | 123,353 | +2.0% | 0.00% | -50.0% |
| Q4 2015 | $1,213,000 | +35.4% | 120,917 | +0.7% | 0.00% | +100.0% |
| Q3 2015 | $896,000 | -87.5% | 120,115 | -20.3% | 0.00% | -88.9% |
| Q2 2015 | $7,150,000 | +84.9% | 150,725 | +42.8% | 0.01% | +80.0% |
| Q1 2015 | $3,868,000 | +30.4% | 105,568 | +41.4% | 0.01% | +25.0% |
| Q4 2014 | $2,966,000 | +132.4% | 74,681 | +16.7% | 0.00% | +100.0% |
| Q3 2014 | $1,276,000 | +49.4% | 63,984 | +1.1% | 0.00% | +100.0% |
| Q2 2014 | $854,000 | +100.9% | 63,302 | +62.3% | 0.00% | 0.0% |
| Q1 2014 | $425,000 | -17.2% | 38,997 | +2.8% | 0.00% | 0.0% |
| Q4 2013 | $513,000 | +39.4% | 37,919 | +17.2% | 0.00% | 0.0% |
| Q3 2013 | $368,000 | +84.0% | 32,367 | +13.9% | 0.00% | – |
| Q2 2013 | $200,000 | – | 28,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |